Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 111

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 111
---
5 $2.1 (7) Charges represent legal and other professional service fees as well as incremental proxy solicitation costs related to a proxy contest. (8) Charges represent professional service fees related to a review of the company's portfolio.(9) Includes indirect costs previously allocated to the Divestiture that are not eligible for discontinued operations accounting treatment. Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Cost of sales$1.4 $2.9 $4.3 $8.7 Selling, general, and administrative expenses2.7 2.9 7.5 9.0 Other (income) expense, net0.1 0.5 (0.1)0.8 Indirect costs allocated to Divestiture$4.2 $6.3 $11.7 $18.5 Depreciation and amortizationThree Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Performance Materials$11.3 $9.7 $31.1 $29.0 Performance Chemicals6.4 6.1 18.3 18.3 Advanced Polymer Technologies8.9 7.9 24.9 23.0 Indirect costs allocated to Divestiture  (1)1.1 1.5 3.1 4.7 Total depreciation and amortization$27.7 $25.2 $77.4 $75.0 _______________(1) Includes indirect costs previously allocated to the Divestiture that are not eligible for discontinued operations accounting treatment. Capital expendituresThree Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Performance Materials$7.4 $8.8 $19.4 $25.4 Performance Chemicals2.8 4.9 5.5 11.8 Advanced Polymer Technologies1.6 3.6 9.0 9.8 Total capital expenditures$11.8 $17.3 $33.9 $47.0 

29

INGEVITY CORPORATIONNotes to the Condensed Consolidated Financial StatementsSeptember 30, 2025(Unaudited)

Total assets In millionsSeptember 30, 2025December 31, 2024Performance